Ko, Andrew H <br/><br/>
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.  [electronic resource] 

 -  The oncologist  12 2017 
 - 1427-e129 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2017-0066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Albumins--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>HSP27 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Oligonucleotides, Antisense--administration & dosage<br/>Paclitaxel--administration & dosage<br/>Pancreatic Neoplasms--blood<br/>Prognosis<br/>Treatment Outcome<br/>Gemcitabine